Biopsy financials
A multi-period view of the public annual-account figures reported for Biopsy, with comparable measures and links to available source documents.
Company overviewRegistry number
0686920346
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 28, 2026
Financial evidence
Latest movements for Biopsy
2025 versus 2024
- Operating line
- €204,844
- EBITDA
- €192,351
- Total assets
- €129,565
- Equity
- €20,460
-18.1%
-18.2%
-35.7%
-79.2%
EBITDA margin +93.9% · Equity ratio +15.8%
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.